Janice Lu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Janice lu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Janice Lu Today - Breaking & Trending Today

Dublin Woman, 36, Dies In Highway 24 Crash

Dublin Woman, 36, Dies In Highway 24 Crash - Dublin, CA - Authorities said she may have suffered a medical emergency that caused her to lose control of her Tesla. ....

Janice Lu , Maggie Fusek , Dublin Woman , Dies In Highway , Contra Costa County Coroner , Pleasant Hill Road , California Highway ,

Orserdu Boosts PFS in ESR1-Mutated Metastatic Breast Cancer Subgroups

Patients with ER-positive, HER2-negative, ESR1-mutant advanced breast cancer experienced improvements in progression-free survival when being treated with Orserdu, study results showed. ....

United States , San Antonio , Janice Lu , Northwestern University Lurie Comprehensive Cancer Center , Antonio Breast Cancer Symposium , Breast Cancer ,

Elacestrant Improves PFS in ESR1-Mutant Metastatic Breast Cancer Subgroups

Treatment with elacestrant led to a clinically meaningful improvement in progression-free-survival compared with standard-of-care therapy among patients with estrogen receptor–positive/HER2-negative, ESR1-mutated advanced or metastatic breast cancer. ....

San Antonio , United States , Janice Lu , Northwestern University Lurie Comprehensive Cancer Center , Antonio Breast Cancer , Bidardf C , Antonio Breast Cancer Symposium ,

Ensuring Access to Oral SERDs

Dr Langer reviews how physicians can ensure that patients get access to oral selective estrogen receptor degraders (SERDs), and the panel of experts provide their closing thoughts. ....

Janice Lu , Lucyr Langer , Ryan Haumschild , Neelima Vidula , Peer Exchange , Estrogen Receptors Degraders , Er Her2 Metastatic Breast Cancer , Advanced Therapies , Access To Care , Clinical Trial Enrollment , Abroad Education ,

Payer Perspectives on SERDs

Dr Langer explores how payers think about the authorization process for DEXA scans and other surveillance activities that would be required for selective estrogen receptor degraders (SERDs) and how oral SERDs affect quality of life. ....

Lucyr Langer , Janice Lu , Ryan Haumschild , Javier Cortes , Enhancing Oncology Model , Estrogen Receptors Degraders , Er Her2 Metastatic Breast Cancer , Payers And Providers , Surveillance Activities , Quality Of Life ,